Related Experiment Video
Updated: Sep 17, 2025
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
Published on: February 23, 2024
Association between iron homeostasis and prognosis in patients with chronic obstructive pulmonary disease: a
Zhenchao Dong1, Chaoqun Xu2, Shanjun Yu3
1The People's Hospital of Danyang and Affiliated Danyang Hospital of Nantong University, Danyang, China.
Introduction:
Accumulating evidence indicates that inflammatory responses can alter iron-related biomarkers, such as serum iron, ferritin, transferrin, and total iron-binding capacity (TIBC). However, in the context of chronic obstructive pulmonary disease (COPD), characterized by airway inflammation, the relationship between its prognosis and iron-related biomarkers has not been comprehensively assessed.
Methods:
Clinical data of 611 COPD patients from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database were retrospectively analyzed. Associations between four iron-related biomarkers-serum iron, ferritin, transferrin, and TIBC-and both long-term and in-hospital mortality in patients with COPD were assessed using the Cox model and the Kaplan-Meier survival analysis. Moreover, receiver operating characteristic curves were used to further evaluate the prognostic predictive ability of these indicators.
Results:
The results suggested that higher levels of serum iron and ferritin were significantly associated with poor long-term prognosis in COPD patients. However, higher levels of transferrin and TIBC may reduce the risk of long-term mortality, serving as protective factors. Furthermore, to a certain degree, these four indicators possessed predictive value for both long-term and in-hospital mortality in patients with COPD.
Conclusion:
This study underscores the critical connection between iron-related biomarkers and the prognosis of COPD patients, contributing valuable insights for risk stratification and clinical management in this demographic. Future studies, both retrospective and prospective, should investigate the effects of dynamic fluctuations in iron-related biomarkers to enhance the treatment and management of COPD.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...